MP
Mangrove Partners’s Protagonist Therapeutics PTGX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.9M | Hold |
395,383
| – | – | 2.35% | 16 |
|
|
2025
Q1 | $19.1M | Hold |
395,383
| – | – | 2.07% | 17 |
|
|
2024
Q4 | $15.3M | Sell |
395,383
-43,931
| -10% | -$1.7M | 1.69% | 22 |
|
|
2024
Q3 | $19.8M | Hold |
439,314
| – | – | 1.7% | 22 |
|
|
2024
Q2 | $15.2M | Hold |
439,314
| – | – | 1.17% | 29 |
|
|
2024
Q1 | $12.7M | Hold |
439,314
| – | – | 0.88% | 35 |
|
|
2023
Q4 | $10.1M | Hold |
439,314
| – | – | 0.68% | 46 |
|
|
2023
Q3 | $7.33M | Buy |
+439,314
| New | +$7.33M | 0.55% | 61 |
|
|
2022
Q1 | – | Sell |
-433,137
| Closed | -$14.8M | – | 471 |
|
|
2021
Q4 | $14.8M | Buy |
+433,137
| New | +$14.8M | 0.88% | 11 |
|